Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma.
about
The biology of uveal melanomaA major responder to ipilimumab and nivolumab in metastatic uveal melanoma with concomitant autoimmunity.Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies.Pembrolizumab use for the treatment of advanced melanoma.Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation.Safety and efficacy profile of pembrolizumab in solid cancer: pooled reanalysis based on randomized controlled trials.Melanoma subtypes demonstrate distinct PD-L1 expression profiles.Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease.Recent advances in uveal melanoma treatment.Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.Treatment of uveal melanoma: where are we now?Current status and perspectives in immunotherapy for metastatic melanoma.Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors.
P2860
Q37742632-422654C9-E9F7-4332-B553-3C199BA77C12Q38713958-90DA43D4-7015-4A90-8C38-200E86082DCDQ38783820-3211EB5C-17F3-4FAD-BC16-F72A0F6EEF48Q39190201-778BEF11-A415-44F3-8BD0-761D5505FF3BQ40060071-BE7DB2E5-B371-4868-BC4B-411420832B96Q42370605-56A28E24-1C16-46B9-93C6-6C0AA9F3B41FQ47107364-8F15A218-BC81-4C24-BD06-EDDD719B4433Q47239043-E136BC9A-39C3-44D8-930E-A073625F82B8Q47571643-2156451A-DB47-46B8-918A-DABF8237D12EQ50057781-0CD6873F-89F4-49A0-BFD4-7FC18918DEA9Q50349181-26403F05-D488-42E5-8CCA-79507AD90472Q54574397-88A43F79-1B0C-4122-804B-4EBD9461F23DQ55135864-1310F6EE-5982-4E8E-9305-979E675FEFFA
P2860
Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical activity and safety o ...... patients with uveal melanoma.
@en
Clinical activity and safety o ...... patients with uveal melanoma.
@nl
type
label
Clinical activity and safety o ...... patients with uveal melanoma.
@en
Clinical activity and safety o ...... patients with uveal melanoma.
@nl
prefLabel
Clinical activity and safety o ...... patients with uveal melanoma.
@en
Clinical activity and safety o ...... patients with uveal melanoma.
@nl
P2860
P50
P1433
P1476
Clinical activity and safety o ...... d patients with uveal melanoma
@en
P2093
Peter W Szlosarek
Pui Ying Chan
P2860
P304
P356
10.1080/2162402X.2016.1143997
P577
2016-02-18T00:00:00Z